These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 16624621

  • 21. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
    Recchia A, Bonini C, Magnani Z, Urbinati F, Sartori D, Muraro S, Tagliafico E, Bondanza A, Stanghellini MT, Bernardi M, Pescarollo A, Ciceri F, Bordignon C, Mavilio F.
    Proc Natl Acad Sci U S A; 2006 Jan 31; 103(5):1457-62. PubMed ID: 16432223
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial.
    Kaiser J.
    Science; 2003 Jan 24; 299(5606):495. PubMed ID: 12543948
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Toxicity of repeated intravenous injection of gene therapeutics for X-CGD in mice.
    Lee YM, Choi WH, Kim YB, Ha CS, Song CW, Lee M, Joo CW, Hong Y, Ho SH, Kim S, Kim JM, Koh WS.
    Hum Exp Toxicol; 2008 May 24; 27(5):401-7. PubMed ID: 18715886
    [Abstract] [Full Text] [Related]

  • 29. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
    Kaiser J.
    Science; 2005 Jun 17; 308(5729):1735-6. PubMed ID: 15961648
    [No Abstract] [Full Text] [Related]

  • 30. Safety and efficacy in retrovirally modified haematopoietic cell therapy.
    Li Z, Modlich U, Baum C.
    Best Pract Res Clin Haematol; 2004 Sep 17; 17(3):493-503. PubMed ID: 15498719
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Gene therapy using hematopoietic stem cells.
    Kohn DB.
    Curr Opin Mol Ther; 1999 Aug 17; 1(4):437-42. PubMed ID: 11713757
    [Abstract] [Full Text] [Related]

  • 33. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
    Sinn PL, Sauter SL, McCray PB.
    Gene Ther; 2005 Jul 17; 12(14):1089-98. PubMed ID: 16003340
    [Abstract] [Full Text] [Related]

  • 34. Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells.
    Siapati EK, Bigger BW, Kashofer K, Themis M, Thrasher AJ, Bonnet D.
    Eur J Haematol; 2007 Apr 17; 78(4):303-13. PubMed ID: 17378892
    [Abstract] [Full Text] [Related]

  • 35. Is retroviral gene marking too dangerous to use?
    Brenner MK, Heslop HE.
    Cytotherapy; 2003 Apr 17; 5(3):190-3. PubMed ID: 12850996
    [No Abstract] [Full Text] [Related]

  • 36. Detection of retroviral integration sites by linear amplification-mediated PCR and tracking of individual integration clones in different samples.
    Schmidt M, Schwarzwaelder K, Bartholomae CC, Glimm H, von Kalle C.
    Methods Mol Biol; 2009 Apr 17; 506():363-72. PubMed ID: 19110638
    [Abstract] [Full Text] [Related]

  • 37. Occurrence of leukaemia following gene therapy of X-linked SCID.
    Kohn DB, Sadelain M, Glorioso JC.
    Nat Rev Cancer; 2003 Jul 17; 3(7):477-88. PubMed ID: 12835668
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Retroviral transduction of IL-7Ralpha into IL-7Ralpha-/- bone marrow progenitors: correction of lymphoid deficiency and induction of neutrophilia.
    Jiang Q, Li WQ, Aiello FB, Klarmann KD, Keller JR, Durum SK.
    Gene Ther; 2005 Dec 17; 12(24):1761-8. PubMed ID: 16208423
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.